Emergence of drug-resistant HIV-1 variants in patients undergoing structured treatment interruptions
- 1 November 2002
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in AIDS
- Vol. 16 (17), 2342-2344
- https://doi.org/10.1097/00002030-200211220-00018
Abstract
We report the emergence of drug-resistant viral mutations in chronically HIV-infected individual undergoing structured treatment interruptions (STI). THe protease mutations K101E and K103N were detected at the end of the second or third STI. We concluded that the repeated abrupt termination and resumption of certain antiretroviral drug regimens during STI therapy may lead to the development of drug resistance in chronically HIV-infected individuals.Keywords
This publication has 15 references indexed in Scilit:
- Selection of drug-resistant HIV-1 mutants in response to repeated structured treatment interruptionsAIDS, 2002
- Short-cycle structured intermittent treatment of chronic HIV infection with highly active antiretroviral therapy: Effects on virologic, immunologic, and toxicity parametersProceedings of the National Academy of Sciences of the United States of America, 2001
- Structured antiretroviral treatment interruptions in chronically HIV-1-infected subjectsProceedings of the National Academy of Sciences of the United States of America, 2001
- The virological and immunological consequences of structured treatment interruptions in chronic HIV-1 infectionAIDS, 2001
- Structured treatment interruptions to control HIV-1 and limit drug exposureTrends in Immunology, 2001
- Transient Mobilization of Human Immunodeficiency Virus (HIV)-Specific CD4 T-Helper Cells Fails To Control Virus Rebounds during Intermittent Antiretroviral Therapy in Chronic HIV Type 1 InfectionJournal of Virology, 2001
- Enhancement of Human Immunodeficiency Virus Type 1–Specific CD4 and CD8 T Cell Responses in Chronically Infected Persons after Temporary Treatment InterruptionThe Journal of Infectious Diseases, 2000
- Structured treatment interruption in chronically HIV-1 infected patients after long-term viral suppressionAIDS, 2000
- Dynamics of viral load rebound and immunological changes after stopping effective antiretroviral therapyAIDS, 1999
- HIV-1 rebound during interruption of highly active antiretroviral therapy has no deleterious effect on reinitiated treatmentAIDS, 1999